Published in Dig Dis Sci on November 01, 1999
Helicobacter Pylori Empiric Treatment in Ulcer Bleeding (HETUB) | NCT00687336
Precise role of H pylori in duodenal ulceration. World J Gastroenterol (2006) 1.11
Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia. World J Gastroenterol (2014) 0.88
Gastric mucin expression in Helicobacter pylori-related, nonsteroidal anti-inflammatory drug-related and idiopathic ulcers. World J Gastroenterol (2012) 0.85
Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer. Dig Dis Sci (2003) 0.81
A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers. Korean J Intern Med (2015) 0.81
The Role of Helicobacter pylori and NSAIDs in the Pathogenesis of Uncomplicated Duodenal Ulcer. Gastroenterol Res Pract (2012) 0.80
Retracted Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers. Dig Dis Sci (2012) 0.78
The influence of etiologic factors on clinical outcome in patients with peptic ulcer bleeding. Dig Dis Sci (2012) 0.77
THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med (1965) 40.52
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA (1994) 8.57
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Campylobacter pylori and peptic ulcer disease. Gastroenterology (1989) 7.42
The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther (1995) 2.74
Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol (1996) 2.43
Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy. J Clin Pathol (1986) 2.38
Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc (1994) 2.36
Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut (1995) 2.20
Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09
Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis. Gut (1989) 2.06
Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot. J Clin Microbiol (1986) 1.85
Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers. Am J Gastroenterol (1996) 1.82
Predictors of duodenal ulcer healing and relapse. Gastroenterology (1981) 1.78
Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. Am J Gastroenterol (1997) 1.63
Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol (1993) 1.61
Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial. Gut (1988) 1.61
Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med (1979) 1.61
Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther (1991) 1.56
A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol (1998) 1.52
Comparison of biopsy and serological methods of diagnosis of Helicobacter pylori infection and the potential role of antibiotics. Am J Gastroenterol (1998) 1.48
Risk factors associated with refractory peptic ulcers. Gastroenterology (1995) 1.47
Campylobacter pylori in patients with gastritis, peptic ulcer, and carcinoma of the stomach in Lanzhou, China. Lancet (1988) 1.45
Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med (1998) 1.30
A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut (1993) 1.27
Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis. Aliment Pharmacol Ther (1991) 1.23
Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol (1998) 1.22
Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci (1991) 1.20
Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol (1991) 1.19
Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci (1987) 1.18
High incidence of Campylobacter-like organisms in endoscopic biopsies from patients with gastritis, with or without peptic ulcer. Digestion (1987) 1.14
Costs of duodenal ulcer therapy with antibiotics. Arch Intern Med (1995) 1.04
Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol (1992) 1.01
Distribution of Helicobacter pylori colonisation and associated gastric inflammatory changes: difference between patients with duodenal and gastric ulcers. J Clin Pathol (1993) 0.98
"Campylobacter pyloridis" and epigastric pain: endoscopic, histological, and bacteriological correlations. Gastroenterol Clin Biol (1987) 0.97
Helicobacter colonization and histopathological profile of chronic gastritis in patients with or without dyspepsia, mucosal erosion and peptic ulcer: a morphological approach to the study of ulcerogenesis in man. Virchows Arch A Pathol Anat Histopathol (1992) 0.95
Duodenal ulcers that are difficult to heal. BMJ (1988) 0.93
Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology. Rev Infect Dis (1991) 0.93
Helicobacter pylori-negative duodenal ulcer. Am J Med (1991) 0.92
Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy. Am J Gastroenterol (1988) 0.89
Prevalence of Campylobacter pylori in duodenal and gastric mucosa--relationship to inflammation. Scand J Gastroenterol Suppl (1988) 0.89
Prolonged effect of omeprazole on the 14C-urea breath test. Am J Gastroenterol (1996) 0.87
Helicobacter pylori and gastric acid output in peptic ulcer disease. Dig Dis Sci (1991) 0.86
Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines. Gastroenterology (1997) 0.85
Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. Endoscopy (1996) 0.82
A cost analysis of alternative treatments for duodenal ulcer. Ann Intern Med (1995) 0.81
Helicobacter pylori in dyspeptic patients in Kuwait. J Clin Pathol (1990) 0.81
Helicobacter pylori-negative duodenal and pyloric ulcer: role of NSAIDs. Digestion (1996) 0.78
[The importance of obtaining biopsies of the gastric body in the follow-up after eradicating treatment of Helicobacter pylori]. Med Clin (Barc) (1995) 0.78
Who should undergo testing for Helicobacter pylori? Am J Gastroenterol (1996) 0.78
Effect of standard and high dose ranitidine on [13C]urea breath test results. Am J Gastroenterol (1998) 0.77
Helicobacter pylori and duodenal ulcer. A study of duodenal ulcer patients and their first-degree relatives. Scand J Gastroenterol Suppl (1991) 0.77
[Helicobacter pylori infection and basal levels of serum gastrins in patients with duodenal ulcer and subjects with normal endoscopy]. Med Clin (Barc) (1996) 0.76
The acid test. Making clinical sense of the Consensus Conference on Helicobacter pylori. JAMA (1994) 0.75
Helicobacter pylori infection status in relation to antibiotic and non-steroidal prescribing in patients on maintenance treatment for chronic duodenal ulcer. Eur J Gastroenterol Hepatol (1997) 0.75
Campylobacter pylori in peptic ulcer disease. II. Endoscopic findings and cultivation of C. pylori. Scand J Gastroenterol (1988) 0.75
[Helicobacter pylori and duodenal ulcer: a causal relation or mere association?]. Rev Clin Esp (1997) 0.75
Campylobacter pylori and gastroduodenal ulcer disease. A prospective study in a Swedish population. Scand J Gastroenterol Suppl (1989) 0.75
Testing for Helicobacter pylori in the diagnosis of Zollinger-Ellison syndrome. Am J Gastroenterol (1991) 0.75
Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori. Scand J Gastroenterol (1996) 0.75
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa]. Rev Esp Enferm Dig (1996) 0.75
[Basal levels of blood pepsinogen I and Helicobacter pylori infection in patients with duodenal ulcer and normal endoscopy]. Rev Esp Enferm Dig (1996) 0.75
Influence of RecA protein on induced mutagenesis. Biochimie (1983) 2.60
Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer? Aliment Pharmacol Ther (2005) 2.12
Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. Aliment Pharmacol Ther (2004) 2.08
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther (2015) 1.99
Characterization of lexB mutations in Escherichia coli K-12. J Bacteriol (1977) 1.99
Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999. J Clin Microbiol (2004) 1.93
Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun (1993) 1.90
Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther (2001) 1.80
Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta (2001) 1.78
Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol (2000) 1.74
Diagnosis of Helicobacter pylori infection by stool antigen determination: a systematic review. Am J Gastroenterol (2001) 1.65
Flp1, a fission yeast orthologue of the s. cerevisiae CDC14 gene, is not required for cyclin degradation or rum1p stabilisation at the end of mitosis. J Cell Sci (2001) 1.63
The 2010 Mw 8.8 Maule megathrust earthquake of Central Chile, monitored by GPS. Science (2011) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Eur J Gastroenterol Hepatol (2001) 1.58
Tonsillectomy and inflammatory bowel disease location. Eur J Gastroenterol Hepatol (1996) 1.57
Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis (1996) 1.54
13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Dig Liver Dis (2000) 1.51
Epidemiologic investigation of a silage-associated epizootic of ovine listeric encephalitis, using a new Listeria-selective enumeration medium and phage typing. Am J Vet Res (1992) 1.51
Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis. Dig Liver Dis (2004) 1.49
High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication. Helicobacter (2001) 1.49
Evidence for two types of cytotoxic necrotizing factor in human and animal clinical isolates of Escherichia coli. J Clin Microbiol (1990) 1.49
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Production of toxins by Escherichia coli strains isolated from calves with diarrhoea in galicia (north-western Spain). Vet Microbiol (1988) 1.47
Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients. Allergol Immunopathol (Madr) (2011) 1.45
Virulence genotypes and serotypes of verotoxigenic Escherichia coli isolated from cattle and foods in Argentina. Importance in public health. Eur J Epidemiol (2000) 1.44
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Aliment Pharmacol Ther (2006) 1.42
Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain. J Clin Microbiol (1997) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies? Dig Liver Dis (2005) 1.40
The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology (2004) 1.40
[Clinical Trials in gastroenterology related to Helicobacter pylori infection]. Acta Gastroenterol Latinoam (2000) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology (1998) 1.39
[Study of the validity of "rapid" serology in diagnosing Helicobacter pylori infection]. Aten Primaria (2002) 1.38
NMDA receptor activation limits the number of synaptic connections during hippocampal development. Nat Neurosci (2001) 1.34
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Diagnosis of alpha-L-iduronidase deficiency in dried blood spots on filter paper: the possibility of newborn diagnosis. Clin Chem (2001) 1.34
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther (2000) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. J Clin Microbiol (1989) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Different efficiency of UmuDC and MucAB proteins in UV light induced mutagenesis in Escherichia coli. Mol Gen Genet (1986) 1.25
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Notch signalling in cancer stem cells. Clin Transl Oncol (2009) 1.19
Revision of the validity of CAMP tests for Listeria identification. Proposal of an alternative method for the determination of haemolytic activity by Listeria strains. Acta Microbiol Hung (1990) 1.18
Serogroups of Escherichia coli strains producing cytotoxic necrotizing factors CNF1 and CNF2. FEMS Microbiol Lett (1992) 1.17
Ghrelin, a novel placental-derived hormone. Endocrinology (2001) 1.17
A microbiological, histopathological and immunohistological study of the intragastric inoculation of Listeria monocytogenes in mice. J Comp Pathol (1992) 1.17
Mutagenic DNA repair in Escherichia coli. XIII. Proofreading exonuclease of DNA polymerase III holoenzyme is not operational during UV mutagenesis. Mutat Res (1987) 1.16
vig-1, a new fish gene induced by the rhabdovirus glycoprotein, has a virus-induced homologue in humans and shares conserved motifs with the MoaA family. J Virol (1999) 1.15
Amino acids critical for the functions of the bovine papillomavirus type 1 E2 transactivator. J Virol (1996) 1.14
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail. Aliment Pharmacol Ther (2002) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Serogroups of Escherichia coli isolated from piglets in Spain. Vet Microbiol (1996) 1.13
O serogroups, biotypes, and eae genes in Escherichia coli strains isolated from diarrheic and healthy rabbits. J Clin Microbiol (1996) 1.13
Evaluation of hemorrhoids with the retroflexed fiberoptic colonoscope. Gastrointest Endosc (1999) 1.12
Virulence factors of bacteraemic Escherichia coli with particular reference to production of cytotoxic necrotising factor (CNF) by P-fimbriate strains. J Med Microbiol (1990) 1.11
Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology (1990) 1.10
Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol (1990) 1.10
Recovery of phage lambda from ultraviolet damage. Basic Life Sci (1975) 1.08
Helicobacter pylori therapy: first-line options and rescue regimen. Dig Dis (2001) 1.08
Community-randomized trial of lambdacyhalothrin-treated hammock nets for malaria control in Yanomami communities in the Amazon region of Venezuela. Trop Med Int Health (2007) 1.07
Enterotoxins, colonization factors and serotypes of enterotoxigenic Escherichia coli from humans and animals. Microbiologia (1991) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Serotypes and virulence genes of ovine non-O157 Shiga toxin-producing Escherichia coli in Switzerland. Int J Food Microbiol (2004) 1.06
Characterization of Shiga toxin-producing Escherichia coli isolated from aquatic environments. FEMS Microbiol Lett (2005) 1.05
The cold pressor test: pharmacological and therapeutic aspects. Am J Ther (1997) 1.05
Production of toxins (enterotoxins, verotoxins, and necrotoxins) and colicins by Escherichia coli strains isolated from septicemic and healthy chickens: relationship with in vivo pathogenicity. J Clin Microbiol (1997) 1.05
A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. Vaccine (2001) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Independent variation of glucagon and epinephrine responsive components of hepatic adenyl cyclase as a function of age, sex and steroid hormones. Endocrinology (1970) 1.04
Serotypes, virulence genes, and intimin types of Shiga toxin-producing Escherichia coli (STEC) and enteropathogenic E. coli (EPEC) isolated from calves in São Paulo, Brazil. Int J Food Microbiol (2007) 1.04
Restoration of RecA protein activity by genetic complementation. Mol Gen Genet (1984) 1.04
Serotypes of Escherichia coli isolated from septicaemic chickens in Galicia (northwest Spain). Vet Microbiol (1998) 1.03
Plasmid pKM101-dependent repair and mutagenesis in Escherichia coli cells with mutations lexB30 tif and zab-53 in the recA gene. Mutat Res (1981) 1.03
Serotypes, virulence genes, intimin types and PFGE profiles of Escherichia coli isolated from piglets with diarrhoea in Slovakia. Vet J (2006) 1.03
Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication. Aliment Pharmacol Ther (2003) 1.02
E. coli K12 inf: a mutant deficient in prophage lambda induction and cell filamentation. Mol Gen Genet (1975) 1.02
Hildebrand and Hansen solubility parameters from molecular dynamics with applications to electronic nose polymer sensors. J Comput Chem (2004) 1.02
Repair mechanisms involved in prophage reactivation and UV reactivation of UV-irradiated phage lambda. Mutat Res (1973) 1.02
Comparative evaluation of three tests for the detection of Escherichia coli cytotoxic necrotizing factors (CNF1 and CNF2) using filtrates of cultures treated with mitomycin C. FEMS Microbiol Lett (1990) 1.01
H pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. J Clin Pathol (1998) 1.01
Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine. J Clin Microbiol (1993) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation. Eur J Endocrinol (2005) 0.99
IexB: a new gene governing radiation sensitivity and lysogenic induction in Escherichia coli K12. Basic Life Sci (1975) 0.98
Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther (2005) 0.98
Phenotypic and genotypic characteristics of non-O157 Shiga toxin-producing Escherichia coli (STEC) from Swiss cattle. Vet Microbiol (2004) 0.97
Tracheoesophageal fistula, gastrointestinal abnormalities, hypospadias, and prenatal growth deficiency. Am J Med Genet (1992) 0.97
The Hha protein as a modulator of expression of virulence factors in Escherichia coli. Infect Immun (1996) 0.97
Detection and characterisation of Shiga toxin-producing Escherichia coli other than Escherichia coli O157:H7 in wild ruminants. Vet J (2008) 0.97
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Aliment Pharmacol Ther (2007) 0.97
Serotypes, virulence genes and intimin types of verotoxin-producing Escherichia coli and enteropathogenic E. coli isolated from healthy dairy goats in Spain. Vet Microbiol (2005) 0.97
Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Aliment Pharmacol Ther (2006) 0.96
Pheno-genotypic characterisation of Escherichia coli O157:H7 isolates from domestic and wild ruminants. Vet Microbiol (2009) 0.96
Influence of the recF143 mutation of Escherichia coli K12 on prophage lambda induction. Mutat Res (1978) 0.96
Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clin Exp Immunol (2008) 0.96